Lipoprotein lipase is a key perpetrator responsible for organizing disequilibrium in the heart during diabetes.
EC and cardiomyocytes support each other to promote lipoprotein lipase transfer to the vascular lumen.
Understanding mechanisms that regulate lipoprotein lipase could provide novel targets for treatment of diabetic cardiomyopathy.